Doug Schenkel
Stock Analyst at Wolfe Research
(2.84)
# 1,615
Out of 5,241 analysts
61
Total ratings
50%
Success rate
33.6%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $42.72 | +40.45% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $332.41 | +44.40% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $95.66 | -21.60% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $15.08 | +112.27% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $43.62 | +37.55% | 1 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $49.71 | +20.71% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $17.75 | +57.75% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $304.32 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $104.23 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $4.09 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $164.16 | +73.61% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $112.11 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $49 | $33.74 | +45.38% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $21.46 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $141.49 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $442.00 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.65 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $95.64 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.16 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $7.63 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $192.58 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.69 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.96 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.76 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.69 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.69 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $16.88 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.54 | +608.66% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $13.52 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $152.48 | -40.98% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.50 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $127.28 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $65.11 | -75.42% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $42.72
Upside: +40.45%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $332.41
Upside: +44.40%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $95.66
Upside: -21.60%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $15.08
Upside: +112.27%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $43.62
Upside: +37.55%
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $49.71
Upside: +20.71%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $17.75
Upside: +57.75%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $304.32
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $104.23
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $4.09
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $164.16
Upside: +73.61%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $112.11
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $49
Current: $33.74
Upside: +45.38%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $21.46
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $141.49
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $442.00
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $3.65
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $95.64
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.16
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $7.63
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $192.58
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.69
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $4.96
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.76
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.69
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.69
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $16.88
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.54
Upside: +608.66%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $13.52
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $152.48
Upside: -40.98%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.50
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $127.28
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $65.11
Upside: -75.42%